Medarova Zdravka 13D and 13G filings for TransCode Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-15 4:00 pm Purchase | 2023-12-31 | 13G | TransCode Therapeutics, Inc. RNAZ | Medarova Zdravka | 3,396 0.400% | 3,396 (New Position) | Filing |